A dispensing practice earns an income stream that most GP practices never see, and it behaves very differently from core contract funding. It is largely a reimbursement of drug cost plus a fee, it turns the practice into a buyer and seller of stock, and its VAT treatment is genuinely unusual: it is the one part of a GP practice that produces zero-rated taxable supplies. This guide explains how dispensing income is generated, how it sits in the practice accounts, how it is taxed, and the VAT position on dispensed drugs, which is the part that trips up most people.

Throughout, every figure (Drug Tariff prices, the dispensing fee scale, the margin and the clawback) is set in the contract and the Tariff and is uplifted, so treat the numbers as current-year and confirm them at source. This page stays at the dispensing-income altitude and hands the wider VAT-registration mechanics to our guide on GP practice VAT registration.

What a Dispensing Practice Is, and Who Can Dispense

A dispensing practice is a GP practice with contractual rights to supply medicines directly to certain of its registered patients. Instead of leaving the surgery with a prescription to take to a pharmacy, an eligible patient leaves with the medicine itself, dispensed by the practice.

Eligibility follows a controlled-area principle. As a general rule, a practice may dispense to patients who live in a designated controlled area and more than one mile (about 1.6 km) from a pharmacy, where the patient would otherwise have serious difficulty obtaining their medicines. The detail sits in the relevant pharmaceutical services regulations and is decided locally, so this is the principle rather than a full legal test. The practical effect is that dispensing practices are predominantly rural and dispense to a defined group of their patients, not to the whole list.

It is worth being precise about two different acts. Every GP prescribes. Only a dispensing practice both prescribes and then dispenses (supplies) the medicine, and is reimbursed for doing so. That distinction is the whole basis of the extra income, the extra accounting and the unusual VAT position that follow.

It also helps to be clear that dispensing status is a feature of the practice and the patient, not of the prescribing decision. The same GP might write a prescription for a dispensing patient (who collects the medicine at the surgery) and for a non-dispensing patient on the same list (who takes the prescription to a pharmacy). Only the first generates dispensing income for the practice. That is why the dispensary keeps its own records of what it has dispensed and to whom, and why those records, not the prescribing list as a whole, drive both the income and the year-end accounting.

How Dispensing Income Is Actually Generated

Dispensing income is not one payment. It is several components that together cover the cost of the drug plus a payment for the work of dispensing. It helps to take them one at a time.

Drug Reimbursement (the Drug Tariff)

The practice is reimbursed for the cost of the medicines it dispenses, at prices set in the NHS Drug Tariff. The Drug Tariff is the national reimbursement price list, published monthly by the NHS Business Services Authority, and it determines how much the practice is paid for each item it supplies against an NHS prescription. Reimbursement claims are processed through the NHSBSA and PCSE route using the GP prescriber number. Because the Tariff is updated monthly, individual drug prices are not fixed facts; confirm the current figure at source rather than relying on any quoted price.

Dispensing Fees

On top of reimbursement, the practice earns a dispensing fee for each item dispensed. The fee sits on a national scale that is uplifted in line with the contract. As with the Tariff, there is no permanent per-item figure to lock down: the fee scale moves, so frame it as set on a national scale and uplifted, and check the current scale when it matters.

The Buying Margin (and Clawback)

Because the practice buys drugs at trade prices but is reimbursed at Tariff prices, there can be a buying margin. The contract is designed to deliver a planned level of margin across the country as a whole, and a margin survey and adjustment mechanism operates so that excess margin is recovered, often described as a clawback or a discount deduction. The point to hold on to is a neutral one: the headline reimbursement is not all profit, because both the purchase cost of the drugs and the margin adjustment reduce it.

Dispensing Quality and Other Components

Additional payments may apply, for example a quality scheme rewarding particular standards in the dispensing service. Treat these as further components that are set, varied and uplifted by the contract, and confirm the current-year detail at source. The general rule for this whole section holds: every figure (the fee scale, the margin, any quality payment) is set in the contract and the Tariff, so it should be framed as current-year and pointed to its source, never asserted as a fixed number.

Putting the components together, the way to picture a dispensing payment is as a stack: a reimbursement that broadly returns the cost of the drugs, a fee for the work of dispensing each item, an adjustment that recovers excess buying margin across the system, and any quality or service payments on top. None of those four is the whole story on its own, and the headline reimbursement figure (the largest of them) is the one least connected to profit, because most of it is simply giving back money the practice has already spent buying stock. Holding that stack in mind is what stops a dispensing practice from over-reading its own turnover.

It is also worth noting where the money is administered. Dispensing reimbursement and fees are processed through the NHSBSA and PCSE, and they appear on the practice's monthly PCSE payment statement alongside its other NHS income. That is convenient (the income arrives through the same channel as core funding) but it also means the dispensing line has to be checked like any other line on the statement, which we return to at the end of this guide.

How Dispensing Income Sits in the Practice Accounts

The key accounting point is that dispensing turns the practice into a business that buys and sells stock. That changes how the accounts read.

Drug reimbursement is income (turnover). The cost of buying those drugs is a matching cost of sale. The difference between the two, after the margin adjustment, is what actually contributes to profit. The gross dispensing turnover can be very large and can dwarf core contract income without adding much to the bottom line. Reading that gross figure as profit is the classic dispensing error, and it is worth flagging in the accounts so partners are not misled by a headline number.

Drug stock. The practice holds drug stock that must be counted and valued at the year-end. Stock on hand is an asset carried forward; only the drugs actually dispensed in the year are a cost of that year. A poor or rushed stock count distorts the dispensing profit, which then flows straight to the partners' shares, so the year-end count is not a formality.

Dispensary staff and overheads. Running a dispensary has real costs: dispensary staff, software, fridges and storage. These are practice costs that should be set against dispensing income to see the true contribution it makes. Only after the matched drug cost, the margin adjustment and these overheads can you see what dispensing actually adds to profit.

It is worth being concrete about why the gross and net figures diverge so far. Imagine a practice whose dispensing reimbursement for a year is a large six-figure sum. The great bulk of that is matched, almost pound for pound, by the cost of buying the drugs it dispensed, and a further slice is removed by the margin adjustment. What is left to add to practice profit is the dispensing fees plus the residual net margin, less the dispensary's running costs. So a dispensing line that looks enormous on the statement can contribute a comparatively modest amount to the bottom line. None of that is a problem; it is simply how a reimbursement-plus-fee model works. The problem only arises if the accounts, or the partners, treat the gross figure as if it were profit when setting drawings or planning tax.

From there the ordinary partnership rule applies. Whatever dispensing contributes to practice profit is trading income, and a partner is taxed on their share of practice profit, not on their drawings. See our complete guide to GP partnership tax for how that works, and our guide to GP partnership profit sharing and tax planning for how shares are agreed. Partnership agreements sometimes treat dispensing profit differently between partners, for example where only some partners carry the dispensing risk or investment; that is a partnership-agreement matter, not a tax rule. For the mechanics of recording it all, see our GP accounting guide and GP bookkeeping guide.

How Dispensing Income Is Taxed

Income tax. Dispensing income is part of the practice's trading profit. There is no separate regime for it; it simply increases the partnership's taxable profit, which is allocated to the partners and taxed on each partner's profit share through the partnership return (SA800) and the partnership pages (SA104) of their personal return. For the full picture of how partnership profit flows to tax, see our complete guide to GP partnership tax.

Capital allowances. Dispensary fit-out and equipment (shelving, fridges, dispensing robots and software) can qualify for capital allowances and the Annual Investment Allowance, just like other practice equipment. We do not repeat the capital-allowance detail here; our guide to the complete list of GP tax deductions covers what qualifies and how.

Pension. Dispensing income is part of NHS-derived profit, so a partner's share of it is pensionable through the NHS Pension Scheme via the Type 1 Annual Certificate of Pensionable Profits. The usual caveat applies: a company cannot hold the GMS or PMS contract, and income routed through a company is not NHS-pensionable. See our guide to GP pension contributions and tax relief for the certification and contribution detail.

The VAT Position on Dispensed Drugs (the Part That Is Genuinely Different)

A dispensing practice is unusual among GP practices because it makes zero-rated taxable supplies. That changes the VAT picture in two ways: it can take the practice over the registration threshold, and once registered it can recover input VAT. The position has three limbs, and getting them in the right boxes matters.

NHS Prescription Drugs the Patient Takes Away Are Zero-Rated

Where the practice dispenses drugs to a patient against an NHS prescription, for the patient's own personal use, to take away, the NHS payment for those drugs is zero-rated, a taxable supply at 0%, not exempt. The statutory home is VATA 1994 Schedule 8 Group 12. This is the crucial distinction from ordinary medical care: because the supply is zero-rated rather than exempt, the practice can recover the input VAT on those drugs. Do not think of dispensed NHS drugs as exempt; that would lose the input-VAT recovery.

Personally Administered Drugs Are Exempt

Drugs and items the doctor administers, injects or applies to the patient in the course of treatment (most vaccines and injections given at the surgery, for example) are part of the single supply of medical care. They are exempt under VATA 1994 Schedule 9 Group 7, not zero-rated, so there is no input-VAT recovery on them. The line between an administered drug and a dispensed drug is therefore a VAT line, not just a clinical one.

Drugs Against a Private Prescription Are Standard-Rated

Where the practice dispenses against a private prescription, VAT may be due at the standard rate. This sits alongside the practice's other standard-rated private work; our guide to a GP practice's private and non-NHS income streams covers that wider private-income picture.

Why the Zero-Rate Matters for Registration and Recovery

Zero-rated dispensing income is taxable turnover, so it counts towards the £90,000 VAT registration threshold, whereas exempt NHS clinical care does not. That is why many dispensing practices are VAT-registered: the zero-rated dispensing income takes them over the threshold even though the clinical work is exempt. Once registered, the practice can recover input VAT on the drugs it buys and on dispensary costs, because those relate to zero-rated supplies. At the same time, the exempt clinical income brings partial exemption into play, restricting recovery on costs that relate to the exempt side. This is a real, recoverable benefit, but it makes the VAT return more complex, with taxable, exempt and outside-the-scope income sitting side by side. We hand the registration and partial-exemption mechanics to our GP practice VAT registration guide rather than repeating them here.

The reason the zero-rate is so valuable, rather than just a technicality, is the contrast with an ordinary GP practice. A practice that makes only exempt supplies cannot register for VAT on the strength of that exempt income and cannot recover input VAT on its costs; the VAT it pays on purchases is simply a cost. A dispensing practice, by contrast, makes a genuine taxable supply every time it dispenses an NHS drug for the patient to take away. Because that supply is taxable (at 0%) rather than exempt, the input VAT attributable to it is recoverable. The 0% rate means the practice charges no VAT to the NHS on the supply, but still gets to reclaim the VAT it incurred in making it, which is the best of both positions. That is the whole commercial logic behind a dispensing practice registering, often voluntarily, even where it is a close call on the threshold.

Two practical cautions follow. First, the recovery is not unlimited: because the practice also has substantial exempt clinical income, partial exemption restricts recovery on shared and exempt-related costs, and the de minimis limits decide how much exempt-related input VAT can still be recovered. Second, the VAT return genuinely is more involved than for a non-registered practice, because every cost has to be considered against three categories of income (taxable, exempt and outside-the-scope NHS funding). That complexity is manageable and well worth the recovery, but it is a reason to get the registration set up correctly from the outset rather than retrofitting it later.

Getting the Dispensing Records Right

Almost everything above depends on good dispensary records, so it is worth pulling the record-keeping points together. Three sets of records do the heavy lifting. The dispensing record itself (what was dispensed, to whom, against which prescription) supports the reimbursement and fee claims and is what you check the PCSE statement against. The drug-purchase record (what was bought, from whom and at what cost) is the matching cost of sale and the basis for input-VAT recovery once registered. And the stock record ties the two together at the year-end, so that only the drugs actually dispensed in the year are charged as a cost of that year.

Where a dispensing practice is VAT-registered, those same records carry a second job: they have to support the VAT treatment, separating zero-rated NHS dispensing from exempt personally administered drugs and from any standard-rated private-prescription work, and identifying the input VAT on purchases. A practice that keeps clean, well-categorised dispensary records finds both the accounts and the VAT return fall out of them with little extra work. A practice that does not tends to discover the gaps at the year-end, when they are hardest to fix. Our GP bookkeeping guide sets out the day-to-day recording, and our GP accounting guide shows how it feeds the year-end accounts.

Common Mistakes and Planning Points

A few issues come up again and again with dispensing practices, and all of them are avoidable:

  • Reading gross dispensing turnover as profit. The reimbursement covers drug cost; the margin and the fees are the point, not the headline number.
  • Weak year-end stock counts distorting the dispensing profit, and therefore every partner's share.
  • Missing VAT registration when zero-rated dispensing income crosses the threshold, and so missing the recoverable input VAT that registration would unlock.
  • Treating personally administered drugs the same as dispensed take-away drugs. They have different VAT liabilities (exempt versus zero-rated).
  • Not reconciling the dispensing income on the PCSE statement against what was actually dispensed. See our guide to reading and reconciling PCSE statements.

It is also worth remembering where dispensing income sits in the wider funding picture. It is an additional NHS stream that only dispensing practices earn, paid against prescriptions, on top of core contract funding. For how that core funding works, see our guide to how GMS funding works through the Global Sum and Carr-Hill. Dispensing income is separate from, and additional to, that core funding.

How We Help Dispensing Practices

Dispensing brings together stock accounting, a buying margin, a careful year-end count and an unusual three-way VAT split, and small errors in any of them feed straight through to the partners' profit shares. We help dispensing practices read their dispensing income correctly (so the gross turnover is not mistaken for profit), value drug stock consistently at the year-end, get the VAT registration and partial-exemption position right so recoverable input VAT is actually recovered, and reconcile the dispensing line on the PCSE statement against what was dispensed. The aim is simple: a clean, accurate picture of what dispensing genuinely contributes, and confidence that the practice is paid and taxed correctly on it.

This guide is general information and not advice for your specific circumstances. For tailored support, see our services for GPs or get in touch with our medical accounting team.